Analytical Data
-
Gene name
LYG2
- Application
-
Alternative Names
LYG2;LYGH;Lysozyme g-like Protein 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q86SG7
-
Expression Region
20-212aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSSYPFSHS MKPHLHPRLY HGCYGDIMTM KTSGATCDAN SVMNCGIRGS EMFAEMDLRA IKPYQTLIKE VGQRHCVDPA VIAAIISRES HGGSVLQDGW DHRGLKFGLM QLDKQTYHPV GAWDSKEHLS QATGILTERI KAIQKKFPTW SVAQHLKGGL SAFKSGIEAI ATPSDIDNDF VNDIIARAKF YKRQSF
-
Molecular Weight
24 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LYG2, a member of the lysozyme gene family, is known for its diverse roles in innate immunity and bacterial clearance. Research into LYG2 recombinant protein has gained traction due to its potential applications in therapeutic development, particularly in combating infections and modulating immune responses. The protein exhibits bacteriolytic activity, which suggests it could be an essential component in developing new antimicrobial agents. Moreover, studies have indicated that LYG2 may play a role in various pathological conditions, including autoimmune diseases and cancer, highlighting its importance in immunological research. The ability to produce LYG2 as a recombinant protein allows for detailed investigations into its structure-function relationships, facilitating the exploration of its mechanisms of action. Understanding the molecular characteristics and biological activities of LYG2 could provide insights into novel strategies for enhancing host defense mechanisms and designing innovative treatments. Hence, ongoing research into LYG2 recombinant protein not only aims to elucidate its biological significance but also to harness its potential for clinical applications, marking a promising avenue in the field of immunology and therapeutic development.
